Rheumatic manifestations of hepatitis B and C and their association with viral load and fibrosis of the liver

Rheumatology International

Volumn 30, Issue 4, 2010, Pages 515-517

  Aydeniz, Ali ^a   Namiduru, M ^a   Karaoglan, I ^a   Altindag, O ^a   Yagiz, E ^a   Gursoy, S ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Fibrosis; Hepatitis; Rheumatologic manifestations; Viral load

Indexed keywords

C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY;

ADULT; ARTHRALGIA; ARTHRITIS; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; FATIGUE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MYALGIA; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RHEUMATIC DISEASE; SHORT FORM 36; VIRUS LOAD; VISUAL ANALOG SCALE; BIOPSY; DISABILITY; JOINT; LIVER; LIVER CIRRHOSIS; MUSCLE DISEASE; PAIN; PATHOLOGY; QUALITY OF LIFE; VIROLOGY;

ADULT; ARTHRALGIA; BIOPSY; DISABILITY EVALUATION; FATIGUE; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; JOINTS; LIVER; LIVER CIRRHOSIS; MALE; MUSCULAR DISEASES; PAIN; PAIN MEASUREMENT; QUALITY OF LIFE; RHEUMATIC DISEASES; VIRAL LOAD;

EID: 77949881938     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-1010-8     Document Type: Article

References (17)

1. Nissen MJ, Fontanges E, Allam Y, Zoulim F, Trépo C, Miossec P (2005) Rheumatological manifestations of hepatitis C: incidence in a rheumatology and non-rheumatology setting and the eVect of methotrexate and interferon. Rheumatology (Oxford) 44:1016-1020. doi:10.1093/rheumatology/keh668 (Pubitemid 41487175)
2. Csepregi A, Rojkovich B, Nemesánszky E, Poór G, Héjjas M, Horányi M (2000) Chronic seropositive polyarthritis associated with hepatitis B virus-induced chronic liver disease: a sequel of virus persistence. Arthritis Rheum 43:232-233. doi:10.1002/1529- 0131(200001)43:1<232::AID-ANR28>3.0.CO;2-O
3. Mariette X (2003) Hepatitis C virus, arthritides, arthromyalgia. Joint Bone Spine 70:246-247. doi:10.1016/S1297-319X(03) 00071-X
4. Lormeau C, Falgarone G, Roulot D, Boissier MC (2006) Rheumatologic manifestations of chronic hepatitis C infection. Joint Bone Spine 73:633-638. doi:10.1016/j.jbspin.2006.05.005 (Pubitemid 44918422)
5. Vassilopoulos D, Calabrese LH (2005) Extrahepatic immunological complications of hepatitis C virus infection. AIDS 19(Suppl 3):S123-S127. doi:10.1097/01.aids.0000192080.56808.38
6. Rosner I, Rozenbaum M, Toubi E, Kessel A, Naschitz JE, Zuckerman E (2004) The case for hepatitis C arthritis. Semin Arthritis Rheum 33:375-387. doi:10.1016/j.semarthrit.2003.12.006 (Pubitemid 38887137)
7. Cacoub P, Ratziu V, Myers RP, Ghillani P, Piette JC, Moussalli J, Poynard T, Multivirc Group (2002) Impact of treatment on extra hepatic manifestations in patients with chronic hepatitis C. J Hepatol 36:812-818. doi:10.1016/S0168- 8278(02)00067-3 (Pubitemid 35177412)
8. Adak B, Tekeoflu I, Ediz L, Budancamanak M, Yazgan T, Karahocagil K, Demirel A (2005) Fibromyalgia frequency in hepatitis B carriers. J Clin Rheumatol 11:157-159. doi:10.1097/01. rhu.0000165291.91623.5c
9. Ngo Y, Benhamou Y, Thibault V, Ingiliz P, Munteanu M, Lebray P et al (2008) An accurate deWnition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (Fibro- Test-ActiTest) and viral load. PLoS ONE 3:e2573. doi:10.1371/ journal.pone.0002573
10. Jessner W, Watkins-Riedel T, Formann E, Steindl-Munda P, Ferenci P (2002) Hepatitis C viral dynamics: basic concept and clinical signiWcance. J Clin Virol 25(Suppl 3):S31-S39. doi:10.1016/ S1386-6532(02)00194-204
11. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J (1981) Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431-435. doi:10.1002/hep.1840010511
12. Von KorV M, Ormel J, Keefe FJ, Dworkin SF (1992) Grading the severity of chronic pain. Pain 50:133-149. doi:10.1016/0304- 3959(92)90154-90164
13. Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473-483. doi:10.1097/00005650-199206000- 00002
14. Han SH (2004) Extrahepatic manifestations of chronic hepatitis B. Clin Liver Dis 8:403-418. doi:10.1016/j.cld.2004.02.003 (Pubitemid 38748611)
15. Ngo Y, Munteanu M, Messous D, Charlotte F, Imbert-Bismut F, Thabut D et al (2006) A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C. Clin Chem 52:1887-1896. doi:10.1373/clinchem.2006.070961 (Pubitemid 44470696)
16. Cacoub P, Renou C, Rosenthal E, Cohen P, Loury I, Loustaud- Ratti V et al (2000) Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. Medicine (Baltimore) 79:47-56. doi:10.1097/00005792- 200001000-200100005
17. Poynard T, Cacoub P, Ratziu V, Myers RP, Dezailles MH, Mercadier A, Ghillani P, Charlotte F, Piette JC, Moussalli J, Multivirc group (2002) Fatigue in patients with chronic hepatitis C. J Viral Hepat 9:295-303. doi:10.1046/j.1365-2893.2002. 00364.x